AnastroHEXAL® 1 mg Filmtabletten




Anastrozole is FDA approved for the adjuvant treatment of postmenopausal women with hormone-positive early breast cancer, for the treatment of postmenopausal women with hormone-positive or locally advanced metastatic breast cancer, and for the treatment of breast cancer in postmenopausal women following Tamoxifen therapy. In all cases, a dosage of 1 mg per day is taken until disease progression is halted. To mitigate the estrogenic side effects of anabolic/androgenic steroids, male athletes and bodybuilders typically take Anastrozole at a dosage of 0.5 mg to 1 mg per day. In some cases, half a tablet (0.5 mg) every other day is an adequate dose to reduce estrogen accumulation. When used in combination with easily aromatizable androgens such as testosterone or methandrostenolone-dianabol, the drug can effectively block gynecomastia and water retention. In addition, Anastrozole can also be used as a fat burner because the process of fat storage is also linked to estrogen levels. As a result of taking the drug, the user can expect an improvement in the physique, which takes on a more embossed, leaner appearance. The drug is of interest to athletes during the dieting/drying phase. It should be noted that the absorption of Anastrozole is not affected by food intake, so the drug can be taken with meals or between meals.

Additional information

Aktive Substanz


Substanzmenge, mg


Freigabe Formular


1 Tablette, mg


Blasen pro Packung, Stck



Hexal AG


1 blase 10 Tabletten, 1 Paket (10 Blase)


There are no reviews yet.

Be the first to review “AnastroHEXAL® 1 mg Filmtabletten”

Your email address will not be published. Required fields are marked *